Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

Inclusion Criteria: * All participants are healthy males * Age range from 21 to 50 years * Broca-Index: within +- 20% of their normal weight * In accordance with Good Clinical Practice (GCP) and local legislation each volunteer is supposed to give their written informed consent prior to admission to the study Exclusion Criteria: * Volunteers will be excluded from the study if the results of the medical examination or laboratory tests are judged by the clinical investigator to differ significantly from normal clinical values * Volunteers with known gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders * Volunteers with diseases of the central nervous system (such as epilepsy) or with psychiatric disorders * Volunteers with history of orthostatic hypotension, fainting spells or blackouts * Volunteers with chronic or relevant acute infections * Volunteers with history of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator * Volunteers who have taken a drug with a long half-life (\>= 24 hours) within one month or less than ten half-lives of the respective drug before enrollment in the study * Volunteers who received any drugs which might influence the results of the trial the week previous to the start of the study * Volunteers who participated in another study with an investigational drug within the last two months preceding this study * Volunteers who smoke (\> 10 cigarettes or 3 cigars or 3 pipes/day) * Volunteers who drink more than 60g of alcohol per day * Volunteers who are dependent on drugs * Volunteers who participated in excessive physical activities (e.g. competitive sports) within the last week before the study * Volunteers who have donated blood within the last 4 weeks (\>= 100 mL)